We have a competitor that offers single-use class IIB products used prior to and after an ABO-incompatible transplantation. It has been well known for the Company for years that one country, Switzerland, re-use the products. This is a violation of the CE mark. In this case, what is the responsiblity of the Company? Should they stop Selling the Products to the Swiss costumers? Can they act as they do not know what is going on with the re-use of single-use Products?